These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1637513

  • 21. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R.
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [Abstract] [Full Text] [Related]

  • 22. Renal protective effect of long term antihypertensive therapy with enalapril.
    Bauer JH, Reams GP.
    Drugs; 1988 Jun; 35 Suppl 5():62-71. PubMed ID: 2850905
    [Abstract] [Full Text] [Related]

  • 23. Effects of a protein load in patients with early chronic renal failure before and after angiotensin II blockade.
    Oldrizzi L, Rugiu C, Maschio G.
    Nephron; 1989 Jun; 52(2):174-7. PubMed ID: 2544820
    [Abstract] [Full Text] [Related]

  • 24. Prevention of loss of renal function over time in patients with diabetic nephropathy.
    Barnett A.
    Am J Med; 2006 May; 119(5 Suppl 1):S40-7. PubMed ID: 16563947
    [Abstract] [Full Text] [Related]

  • 25. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH.
    Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
    [Abstract] [Full Text] [Related]

  • 26. Blood pressure and progression of renal failure in the elderly.
    Acone D, Cante D, Cillo F, Giordano G, Giordano C.
    Kidney Int Suppl; 1996 Jun; 55():S75-7. PubMed ID: 8743516
    [Abstract] [Full Text] [Related]

  • 27. Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy.
    Jacobsen P, Andersen S, Rossing K, Jensen BR, Parving HH.
    Kidney Int; 2003 May; 63(5):1874-80. PubMed ID: 12675866
    [Abstract] [Full Text] [Related]

  • 28. Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.
    Hansen HP, Nielsen FS, Rossing P, Jacobsen P, Jensen BR, Parving HH.
    Kidney Int Suppl; 1997 Dec; 63():S49-53. PubMed ID: 9407421
    [Abstract] [Full Text] [Related]

  • 29. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
    Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH.
    Kidney Int; 2001 Jul; 60(1):277-83. PubMed ID: 11422762
    [Abstract] [Full Text] [Related]

  • 30. [Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
    Osterziel KJ, Nagel F, Dietz R.
    Z Kardiol; 1994 Jul; 83 Suppl 4():81-7. PubMed ID: 7856286
    [Abstract] [Full Text] [Related]

  • 31. Short-term effect of angiotensin-converting enzyme inhibitor enalapril in incipient diabetic nephropathy.
    Abu-Romeh SH, Nawaz MK, Ali JH, Al-Suhaili AR, Abu-Jayyab AK.
    Clin Nephrol; 1989 Jan; 31(1):18-21. PubMed ID: 2536602
    [Abstract] [Full Text] [Related]

  • 32. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
    Delles C, Jacobi J, John S, Fleischmann I, Schmieder RE.
    Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
    [Abstract] [Full Text] [Related]

  • 33. Renal protective effect of enalapril in diabetic nephropathy.
    Björck S, Mulec H, Johnsen SA, Nordén G, Aurell M.
    BMJ; 1992 Feb 08; 304(6823):339-43. PubMed ID: 1540729
    [Abstract] [Full Text] [Related]

  • 34. Retarding progression of chronic renal disease: the neglected issue of residual proteinuria.
    Ruggenenti P, Perna A, Remuzzi G, GISEN Group Investigators.
    Kidney Int; 2003 Jun 08; 63(6):2254-61. PubMed ID: 12753315
    [Abstract] [Full Text] [Related]

  • 35. Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.
    Lebovitz HE, Wiegmann TB, Cnaan A, Shahinfar S, Sica DA, Broadstone V, Schwartz SL, Mengel MC, Segal R, Versaggi JA.
    Kidney Int Suppl; 1994 Feb 08; 45():S150-5. PubMed ID: 8158885
    [Abstract] [Full Text] [Related]

  • 36. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.
    Schrier RW, Estacio RO, Esler A, Mehler P.
    Kidney Int; 2002 Mar 08; 61(3):1086-97. PubMed ID: 11849464
    [Abstract] [Full Text] [Related]

  • 37. Effect of enalapril on glomerular filtration rate and proteinuria in children with chronic kidney disease: a randomized controlled trial.
    Hari P, Sahu J, Sinha A, Pandey RM, Bal CS, Bagga A.
    Indian Pediatr; 2013 Oct 08; 50(10):923-8. PubMed ID: 23585423
    [Abstract] [Full Text] [Related]

  • 38. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
    Svarstad E, Myking O, Ofstad J, Iversen BM.
    Scand J Urol Nephrol; 2002 Oct 08; 36(6):464-72. PubMed ID: 12623513
    [Abstract] [Full Text] [Related]

  • 39. Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.
    Mosconi L, Ruggenenti P, Perna A, Mecca G, Remuzzi G.
    Kidney Int Suppl; 1996 Jun 08; 55():S91-3. PubMed ID: 8743521
    [Abstract] [Full Text] [Related]

  • 40. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
    Lacourcière Y, Bélanger A, Godin C, Hallé JP, Ross S, Wright N, Marion J.
    Kidney Int; 2000 Aug 08; 58(2):762-9. PubMed ID: 10916100
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.